<unk>  is not believed to be associated with clinically significant drug interactions due to inhibition or stimulation of hepatic metabolism. Thus, it should not, for the most part, require special clinical or laboratory monitoring to ensure its safety.<unk>  has a potential for a serious drug interaction with NSAIDs. The combination of corticosteroids and<unk>  has increased potential to result in tendonitis and disability. Antacids containing aluminium or magnesium ions inhibit the absorption of<unk> . Drugs that prolong the QT interval (e.g., pimozide) may have an additive effect on QT prolongation and lead to increased risk of ventricular arrhythmias. The international normalised ratio may be increased or decreased in patients treated with warfarin.
Moxifloxacin
Telithromycin
Azithromycin
Dirithromycin
Roxithromycin
Amikacin
Gemifloxacin
Levofloxacin